Vanguard Group Portfolio holdings
AUM
$6.18T
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Quarter Return
+9.13%
1 Year Return
+25.19%
3 Year Return
+103.99%
5 Year Return
+190.29%
10 Year Return
+458.75%
AUM
$4.02T
AUM Growth
+$4.02T
(+8.7%)
Cap. Flow
+$51.6B
Cap. Flow
% of AUM
1.28%
Top 10 Holdings %
Top 10 Hldgs %
19.45%
Holding
4,508
New
175
Increased
2,890
Reduced
1,225
Closed
84
Top Buys
| 1 |
CSX Corp
CSX
|
$3.98B |
| 2 |
Sherwin-Williams
SHW
|
$3.75B |
| 3 |
Apple
AAPL
|
$3.5B |
| 4 |
Trade Desk
TTD
|
$2.74B |
| 5 |
CoStar Group
CSGP
|
$2.58B |
Top Sells
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
$1.73B |
| 2 |
Alibaba
BABA
|
$913M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
$858M |
| 4 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
$812M |
| 5 |
RP
RealPage, Inc.
RP
|
$736M |
Sector Composition
| 1 | Technology | 23.2% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Communication Services | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Salarius Pharmaceuticals
SLRX
$2.94M
| $1.64M | ﹤0.01% | 1,544,724 +124,192 | +9% | +$132K |
|
4027
BioCardia
BCDA
$11.5M
| $1.64M | ﹤0.01% | 411,969 +166,396 | +68% | +$661K |
|
|
QXO
4028
QXO Inc
QXO
$13.6B
| $1.64M | ﹤0.01% | 134,310 +107,190 | +395% | +$1.3M |
|
|
BLPH
4029
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.63M | ﹤0.01% | 336,966 -22,193 | -6% | -$107K |
|
|
IMPL
4030
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $1.63M | ﹤0.01% | +183,753 | New | +$1.63M |
|
|
ACOR
4031
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $1.62M | ﹤0.01% | 340,481 +68,240 | +25% | +$325K |
|
4032
Aegon
AEG
$12.3B
| $1.62M | ﹤0.01% | 391,126 +78,803 | +25% | +$325K |
|
4033
Air Industries Group
AIRI
$15.2M
| $1.59M | ﹤0.01% | 1,225,840 | – | – |
|
|
MTVA
4034
MetaVia Inc. Common Stock
MTVA
$15.3M
| $1.59M | ﹤0.01% | 477,918 -206,394 | -30% | -$688K |
|
|
TRMT
4035
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
| $1.57M | ﹤0.01% | 259,372 +164,781 | +174% | +$1,000K |
|
4036
Nine Energy Service
NINE
$29.8M
| $1.57M | ﹤0.01% | 534,386 +115,026 | +27% | +$338K |
|
4037
Hudson Global
HSON
$32.9M
| $1.57M | ﹤0.01% | 88,827 | – | – |
|
4038
Coffee Holding Co
JVA
$23.9M
| $1.56M | ﹤0.01% | 290,906 | – | – |
|
|
DVLT
4039
Datavault AI Inc. Common Stock
DVLT
$34.9M
| $1.56M | ﹤0.01% | 388,308 +277,843 | +252% | +$1.11M |
|
|
MTCR
4040
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $1.55M | ﹤0.01% | 408,080 +160,809 | +65% | +$611K |
|
|
CYTH
4041
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $1.55M | ﹤0.01% | 151,540 +117,895 | +350% | +$1.21M |
|
|
SCX
4042
DELISTED
The L.S. Starrett Company
SCX
| $1.55M | ﹤0.01% | 165,528 +23,522 | +17% | +$220K |
|
4043
YPF
YPF
$12B
| $1.54M | ﹤0.01% | 329,317 -84,715 | -20% | -$396K |
|
4044
Evoke Pharma
EVOK
$8.49M
| $1.53M | ﹤0.01% | 1,120,178 -17,335 | -2% | -$23.7K |
|
|
FFBW
4045
DELISTED
FFBW, Inc. Common Stock
FFBW
| $1.53M | ﹤0.01% | 134,579 -50,492 | -27% | -$576K |
|
4046
RCM Technologies
RCMT
$201M
| $1.53M | ﹤0.01% | 371,287 +120,038 | +48% | +$495K |
|
4047
Enliven Therapeutics
ELVN
$1.2B
| $1.51M | ﹤0.01% | 191,411 -38,698 | -17% | -$306K |
|
|
LBPH
4048
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.51M | ﹤0.01% | 165,545 +110,545 | +201% | +$1.01M |
|
|
CYT
4049
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $1.5M | ﹤0.01% | +70,000 | New | +$1.5M |
|
|
ADIL
4050
Adial Pharmaceuticals
ADIL
$8.29M
| $1.49M | ﹤0.01% | 585,035 +370,238 | +172% | +$944K |
|